Nasopharyngeal Cancer
Links shared publicly online about this topic
What is nasopharyngeal cancer?
cancer.org — “Nasopharyngeal cancer develops in the nasopharynx, an area in the back of the nose toward the base of skull.” View full resource at cancer.org
Most Recently Shared on October 19, 2011 at 12:02 am By:
Nasopharyngeal Cancer - Thomas Jefferson University Hospitals
jeffersonhospital.org — “For expert diagnosis and treatment of nasopharyngeal cancer, turn to the otolaryngologists (ear, nose and throat physicians) at Jefferson.” View full resource at jeffersonhospital.org
Most Recently Shared on October 19, 2011 at 12:08 am By:
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 18, 2009 at 4:17 am By:
#ClinicalTrial recruiting Hodgkin pts 4 CAM stdy of electro-acupuncture to relieve chemo nausea. Across US & Halifax, CA http://bit.ly/ayjSc
Nasopharyngeal Neoplasms on #MDlinx
mdlinx.com — “Nasopharyngeal Neoplasms on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 20, 2010 at 1:16 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Factors associated with nodal metastasis in nasopharyngeal cancer: an approach to reduce the radiation field i... http://bit.ly/cu4q7q #ENT
Oncology Article | Cisplatin Radiotherapy Nasopharyngeal Neoplasms
mdlinx.com — “Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer” View full resource at mdlinx.com
Most Recently Shared on March 15, 2011 at 6:22 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated r... http://bit.ly/dPpXSu #oncology
ENT Medical News about Nasopharyngeal Neoplasms
mdlinx.com — “Treatment approaches to nasopharyngeal carcinoma: a review” View full resource at mdlinx.com
Most Recently Shared on April 28, 2010 at 3:13 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Treatment approaches to nasopharyngeal carcinoma: a review: Anti-Cancer Drugs http://bit.ly/b3MOop #ENT #mdlinx
Oncology Medical News about Nasopharyngeal Neoplasms
mdlinx.com — “Treatment approaches to nasopharyngeal carcinoma: a review” View full resource at mdlinx.com
Most Recently Shared on April 29, 2010 at 9:21 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Treatment approaches to nasopharyngeal carcinoma: a review: Anti-Cancer Drugs http://bit.ly/aGB3De #oncology
Otolaryngology News & Articles - MDLinx - Nasopharyngeal Neoplasms on #MDlinx
mdlinx.com — “Otolaryngology News & Articles - MDLinx - Nasopharyngeal Neoplasms on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 14, 2010 at 12:11 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer: Head & Neck http://bit.ly/cuOZT3 #ENT #mdlinx
ENT Medical News about Nasopharyngeal Neoplasms
mdlinx.com — “Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma” View full resource at mdlinx.com
Most Recently Shared on June 30, 2010 at 8:28 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma: BMC Cancer http://bit.ly/964abR #ENT #mdlinx
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab
medicalnewstoday.com — “The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side e” View full resource at medicalnewstoday.com
Most Recently Shared on December 20, 2011 at 8:05 am By:
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab http://t.co/x9DNvHxG #cancer
Nasopharyngeal Carcinoma In Phase II Trial - Bevacizumab Reduced Spread
medicalnewstoday.com — “A new phase II trial published Online First in The Lancet Oncology, reveals that the combination of standard chemoradiation therapy with the popular cancer drug bevacizumab is safe and may” View full resource at medicalnewstoday.com
Most Recently Shared on December 17, 2011 at 8:53 am By:
Ear, Nose, and Throat OW Health
Nasopharyngeal Carcinoma In Phase II Trial - Bevacizumab Reduced Spread: A new phase II trial published Online F... http://t.co/cUktSUlP
Oncology Article | Alcohol Drinking Smoking Tobacco Nasopharyngeal Neoplasms
mdlinx.com — “Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population” View full resource at mdlinx.com
Most Recently Shared on April 12, 2011 at 7:16 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal canc... http://bit.ly/e4ktu4 #oncology
3 New Susceptibility Genes Identified In Genome-Wide Association Study Of Nasopharyngeal Carcinoma
medicalnewstoday.com — “Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 12:26 pm By:
3 New Susceptibility Genes Identified In Genome-Wide Association Study Of Nasopharyngeal Carcinoma http://ow.ly/17zyW8
Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma
news-medical.net — “Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the ” View full resource at news-medical.net
Most Recently Shared on May 31, 2010 at 6:25 am By:
Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma: Scienti... http://bit.ly/cZIbjt
HPV Tied to Rare Head-and-Neck Cancer
health.msn.com — “HPV Tied to Rare Head-and-Neck Cancer” View full resource at health.msn.com
Most Recently Shared on October 9, 2009 at 8:29 pm By:
HPV Tied to Rare Head-and-Neck Cancer http://bit.ly/FTmvo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Joseph M. Curry, MD
Dr. Curry specializes in the care of patients with disorders of the head and neck. This includes patients with cancers of tha larynx (voice box), oral cavity, nasal cavity and sinuses, and pharynx (throat: tonsils and base of tongue). In addition, we treat diseases of the salivary glands and surgical disorders of the thyroid.
Dr. Curry completed his medical school training at Georgetown University and his residency at Thomas Jefferson University. He completed a fellowship in advanced head and neck surgical oncology and microvascular reconstruction at the University of Miami.
The management of head and neck cancers often requires a multidisciplinary approach involving cancer and reconstructive surgeons and medical and radiation oncologists. We coordinate this care with our speech and swallowing specialists, nutritionists, cancer care coordinator and specialized nursing staff to optimize the care of our patients. As a team we strive to deliver effective, rapid, and coordinated care to our patients as they deal with the complex issues surrounding their health. -
Joseph M. Curry, MD
Dr. Curry specializes in the care of patients with disorders of the head and neck. This includes patients with cancers of tha larynx (voice box), oral cavity, nasal cavity and sinuses, and pharynx (throat: tonsils and base of tongue). In addition, we treat diseases of the salivary glands and surgical disorders of the thyroid.
Dr. Curry completed his medical school training at Georgetown University and his residency at Thomas Jefferson University. He completed a fellowship in advanced head and neck surgical oncology and microvascular reconstruction at the University of Miami.
The management of head and neck cancers often requires a multidisciplinary approach involving cancer and reconstructive surgeons and medical and radiation oncologists. We coordinate this care with our speech and swallowing specialists, nutritionists, cancer care coordinator and specialized nursing staff to optimize the care of our patients. As a team we strive to deliver effective, rapid, and coordinated care to our patients as they deal with the complex issues surrounding their health. -
Lymphomation.org
Lymphomation.org/Patients Against Lymphoma -- Providing support and timely access to evidence-based information on lymphomas and their treatment.
Advertisement
